H3Africa Collaborative Centers

AWI-Gen 2: Genomic and Environmental Risk Factors for Cardiometabolic Disease in Africans


The Goal

AWI-Gen is working to understand how genes, environment, and lifestyle affect cardiovascular and metabolic health across Africa and to uncover new insights that could help to improve the health of Africans.

Principal Investigator:

Prof Michele Ramsay

University of Witwatersrand


The Problem

Due to advances in the field of genetics and genomics, researchers now have the ability to understand how one’s DNA and their environment can play a role in their susceptibility to obesity, hypertension, and diabetes – but only in western populations. African populations have been routinely omitted from this fundamental research, keeping them from accessing basic public health strategies.

Project Strategy

  1. Survey 12,000 participants across the continent for information regarding lifestyle, environment, and medical history.
  2. Collect blood and urine samples from participants to measure genomic and metabolic health factors.
  3. Use this information to explore genetic contributions and gene-by-environment interactions on susceptibility for traits like obesity, hypertension and diabetes.
  4. Use insights to support development of better prevention and treatment strategies and to inform public policy.

Outcomes to Date

So far, AWI-Gen has found that obesity disproportionately affects women in southern and eastern Africa and is linked to increased prevalence of diabetes. There is regional variation in the prevalence of hypertension, with a lack of awareness of high blood pressure,. Although some are aware of their status and on medication, their blood pressure remains poorly controlled. Genetic studies have shown that people from the same region and ethnicity tend to cluster together, and that there are differences between the people from western, eastern and southern Africa. Geographic isolation and local adaption to their environments may in part account for these differences.

Project Sites

A. South Africa, WITS Health Consortium, University of the Witwatersrand

B. South Africa, University of Limpopo

C. Ghana, Navrongo Health Research Center

D. Burkina Faso, Clinical Research Center of Nanoro

E. Kenya, African Population and Health Research Center

Non-African Collaborators
USA: Harvard University, Stanford University, University of Colorado
UK: University of Bristol, University of Leicester & Wellcome Trust Sanger Institut

October 16, 2018

AWI-GEN 2: Genomic and Environmental Risk Factors for Cardiometabolic Disease in Africans

AWI-Gen is the Africa Wits-INDEPTH partnership for Genomic Studies, an NIH funded and university supported Collaborative Center of the Human Heredity and Health in Africa
April 19, 2018

Dr. salako Babatunde

University of Ghana Medical School/strong>
April 19, 2018

Dr. Adeyinka Ashaye

University of Ibadan College of Medicine, Nigeria
April 17, 2018

Development of H3 Africa Biorepositories to Facilitate Studies on Biodiversity, Disease & Pharmacogenomics of African Populations

April 17, 2018

Dr. Gordon Awandare

University of Ghana, Ghana
April 17, 2018

Dr. Solomon Ofori-Acquah 

University of Ghana, Ghana
April 6, 2018

H3Africa Adminisrative Coordinating Centre: Enabling and Supporting Genomics and Health Research Capacity Building in Africa

The Human Heredity and Health in Africa (H3Africa) Consortium aims to influence continent- wide research capacity in health and genomics through support from the National Institutes of Health and the Wellcome Trust. H3Africa has approximately 500 members from 26 different projects,
April 6, 2018

H3Africa Kidney Disease Research Network

H3Africa Kidney Disease Research Network Principal Investigator: Dwomoa Adu Principal Investigator: Akinlolu […]
April 6, 2018

Eyes of Africa: The Genetics of Blindness

“Eyes of Africa: The Genetics of Blindness” will address the staggering economic, societal, and personal cost of irreversible blindness in Africa. The most common cause of permanent